Solesence, Inc. Files 8-K for Material Agreement
Ticker: SLSN · Form: 8-K · Filed: Nov 6, 2025 · CIK: 883107
Sentiment: neutral
Topics: material-agreement, filing
Related Tickers: SLSN
TL;DR
Solesence (SLSN) filed an 8-K for a material agreement, check it out.
AI Summary
On November 6, 2025, Solesence, Inc. reported on entering into a material definitive agreement and filed financial statements and exhibits. The earliest event reported was on October 31, 2025. The company, formerly known as Nanophase Technologies Corp, is incorporated in Delaware and headquartered in Romeoville, Illinois.
Why It Matters
This filing indicates a significant business development for Solesence, Inc., potentially impacting its operations and financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's future performance.
Key Players & Entities
- Solesence, Inc. (company) — Registrant
- Nanophase Technologies Corp (company) — Former company name
- November 6, 2025 (date) — Date of Report
- October 31, 2025 (date) — Earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Romeoville, Illinois (location) — Principal Executive Offices
FAQ
What is the nature of the material definitive agreement Solesence, Inc. entered into?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on October 31, 2025.
What was Solesence, Inc. formerly known as?
Solesence, Inc. was formerly known as Nanophase Technologies Corp and Nanophase Technologies CORPORATION.
Where are Solesence, Inc.'s principal executive offices located?
Solesence, Inc.'s principal executive offices are located at 1319 Marquette Drive, Romeoville, Illinois, 60446.
What is the SEC file number for Solesence, Inc.?
The SEC file number for Solesence, Inc. is 001-42589.
Filing Stats: 524 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2025-11-06 16:14:54
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value per share SLSN The NASDAQ S
- $675,000 — lsence a one-time settlement payment of $675,000 on or before January 15, 2026. The des
Filing Documents
- slsn-8k_110625.htm (8-K) — 21KB
- ex10-1.htm (EX-10.1) — 38KB
- 0001999371-25-017120.txt ( ) — 232KB
- slsn-20251106.xsd (EX-101.SCH) — 3KB
- slsn-20251106_lab.xml (EX-101.LAB) — 34KB
- slsn-20251106_pre.xml (EX-101.PRE) — 22KB
- slsn-8k_110625_htm.xml (XML) — 4KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. On October 31, 2025, Solsence, Inc. and its subsidiary Solsence, LLC (collectively, "Solsence") entered into a Confidential Settlement Agreement and Release (the "Settlement Agreement") with Solarium Brands, LLC and A-Frame Brands, LLC (collectively, "Solarium"). Pursuant to the Settlement Agreement, Solsence and Solarium agreed to settle and compromise disputes relating to certain consumer care products previously sold by Solsence to Solarium. As part of the Settlement Agreement, Solarium agreed to pay to Solsence a one-time settlement payment of $675,000 on or before January 15, 2026. The description of the terms and conditions of the Settlement Agreement does not purport to be complete and is qualified in its entirety by the full text of the Settlement Agreement, which is filed, with confidential portions redacted, as an exhibit to this Current Report on Form 8-K.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Confidential Settlement Agreement and Release, dated October 31, 2025.* 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Confidential portions of this exhibit have been redacted.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: November 6, 2025 SOLSENCE, INC. By: /s/ LAURA RIFFNER Name: Laura Riffner Title: Chief Financial Officer